JP2025542410A - アミリン受容体作動薬 - Google Patents

アミリン受容体作動薬

Info

Publication number
JP2025542410A
JP2025542410A JP2025537069A JP2025537069A JP2025542410A JP 2025542410 A JP2025542410 A JP 2025542410A JP 2025537069 A JP2025537069 A JP 2025537069A JP 2025537069 A JP2025537069 A JP 2025537069A JP 2025542410 A JP2025542410 A JP 2025542410A
Authority
JP
Japan
Prior art keywords
compound
receptor agonist
amylin receptor
amylin
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025537069A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025542410A5 (https=
Inventor
セシリー・ミア・ヨルゲンセン
トーマス・クルーセ
イェスパー・エフ・ラウ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US18/512,512 external-priority patent/US12116388B2/en
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of JP2025542410A publication Critical patent/JP2025542410A/ja
Publication of JP2025542410A5 publication Critical patent/JP2025542410A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP2025537069A 2022-12-22 2023-12-21 アミリン受容体作動薬 Pending JP2025542410A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP22215958.4 2022-12-22
EP22215958 2022-12-22
US18/512,512 2023-11-17
US18/512,512 US12116388B2 (en) 2022-12-22 2023-11-17 Amylin receptor agonists
PCT/EP2023/087353 WO2024133739A1 (en) 2022-12-22 2023-12-21 Amylin receptor agonists

Publications (2)

Publication Number Publication Date
JP2025542410A true JP2025542410A (ja) 2025-12-25
JP2025542410A5 JP2025542410A5 (https=) 2026-04-08

Family

ID=89542238

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025537069A Pending JP2025542410A (ja) 2022-12-22 2023-12-21 アミリン受容体作動薬

Country Status (12)

Country Link
EP (1) EP4638480A1 (https=)
JP (1) JP2025542410A (https=)
KR (1) KR20250127104A (https=)
CN (1) CN120435491A (https=)
AU (1) AU2023411346A1 (https=)
CL (1) CL2025001805A1 (https=)
CO (1) CO2025008319A2 (https=)
IL (1) IL321586A (https=)
JO (1) JOP20250144A1 (https=)
MX (1) MX2025007124A (https=)
TW (1) TW202428309A (https=)
WO (1) WO2024133739A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008006A1 (en) 1992-09-30 1994-04-14 Zymogenetics, Inc. Human calcitonin receptor
ES2401965T3 (es) 2009-02-19 2013-04-25 Novo Nordisk A/S Modificación de Factor VIII
JP6121992B2 (ja) 2011-06-10 2017-04-26 ノヴォ ノルディスク アー／エス ポリペプチド
AR097701A1 (es) * 2013-09-19 2016-04-13 Zealand Pharma As Análogos de amilina
JP6898518B2 (ja) 2018-02-02 2021-07-07 ノヴォ ノルディスク アー／エス Ｇｌｐ−１アゴニスト、ｎ−（８−（２−ヒドロキシベンゾイル）アミノ）カプリル酸の塩及び滑沢剤を含む固形組成物
TWI829687B (zh) 2018-05-07 2024-01-21 丹麥商諾佛 儂迪克股份有限公司 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物

Also Published As

Publication number Publication date
TW202428309A (zh) 2024-07-16
KR20250127104A (ko) 2025-08-26
CN120435491A (zh) 2025-08-05
EP4638480A1 (en) 2025-10-29
CO2025008319A2 (es) 2025-07-17
CL2025001805A1 (es) 2025-09-26
MX2025007124A (es) 2025-07-01
IL321586A (en) 2025-08-01
AU2023411346A1 (en) 2025-07-24
WO2024133739A1 (en) 2024-06-27
JOP20250144A1 (ar) 2025-06-16

Similar Documents

Publication Publication Date Title
US12054528B2 (en) Co-agonists of the GLP-1 and amylin receptors
TWI810606B (zh) Gip/glp1共促效劑化合物
US10604555B2 (en) GIP derivatives and uses thereof
EP3068421B1 (en) Selective pyy compounds and uses thereof
JP7484018B2 (ja) Ｇｌｐ－１プロドラッグおよびその使用
EP3189071B1 (en) Novel amylin and calcitonin receptor agonist
US9988430B2 (en) Stable GLP-1 based GLP-1/glucagon receptor co-agonists
TW201542588A (zh) 糊精類似物
JP2024015148A (ja) プロドラッグおよびその使用
US12116388B2 (en) Amylin receptor agonists
JP2025542410A (ja) アミリン受容体作動薬
JP7755031B2 (ja) Ｇｌｐ－１、ｇｉｐ、およびアミリン受容体の三重作動薬
EA049130B1 (ru) Коагонисты рецепторов glp-1 и gip, подходящие для пероральной доставки

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250624

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260330

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260330

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20260330

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260421